Venus Remedies Concludes AMR Licensing Agreement with Receipt of Final ₹11 Crore Milestone
MM Desk
10 December, 2025
Venus Remedies Ltd (NSE: VENUSREM, BSE: 526953) announced that it has received the final milestone